Vinge advised Abliva on the deal. Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of...
You must be a Standard 1 Year member to access this content.
Vinge advised Carasent on the deal. Carasent AB (publ) completed the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent...
You must be a Standard 1 Year member to access this content.
Vinge advised Orlando Capital V on the deal. Orlando Capital V finalized the acquisition of Swedpaper AB, a leading European manufacturer of white sack and kraft...
You must be a Standard 1 Year member to access this content.
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a directed share issue of SEK 184 million and a tender offer for...
You must be a Standard 1 Year member to access this content.
Vinge advised Active Biotech on the offering. Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 million. Active Biotech...
You must be a Standard 1 Year member to access this content.
Vinge advised EHF on the deal. EHF AB has made a public offer for all shares in Götenehus Group AB (publ). EHF and Erik Hemberg privately...
You must be a Standard 1 Year member to access this content.
Vinge advised Carnegie Investment Bank AB on the deal. Carnegie Investment Bank AB completed the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser...
You must be a Standard 1 Year member to access this content.
Vinge advised SAGA Diagnostics in connection with the transaction. SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue...
You must be a Standard 1 Year member to access this content.
Vinge advised Axel Johnson on the deal. Axel Johnson AB, through its wholly-owned subsidiary, AxMedia AB, announced that Axel Johnson had acquired an additional 2,000,000 shares in...
You must be a Standard 1 Year member to access this content.
Vinge has, together with Norton Rose Fulbright, advised Anglo American Limited in the deal. Anglo American Limited entered into a royalty agreement of USD 10 million and a...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Nordea and Pareto on the deal. Vinge has advised Re:NewCell. Re:NewCell AB (publ) has carried out a primary issuance of shares of approximately...
You must be a Standard 1 Year member to access this content.
Vinge advised Öhlin Holding on the deal. KANTER has assisted myFC Holding. K Öhlin Holding has announced a recommended public takeover offer to the shareholders in...
You must be a Standard 1 Year member to access this content.
